← Back to ORKA

Oruka Therapeutics, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 10/08/2026Mar 2026Filed 10/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 10/08/2026Mar 2025Filed 10/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 11/08/2025Mar 2024Filed 01/08/2024
$0
−$41−$32−$30−$25−$21−$29−$22−$2
−$0.46−$0.40−$1.46−$6.96−$0.14
4242153.215

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.